Golden Lee Scott (CIK 1686217) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-06). Recent activity: Sell PTCT (829 shares), Sell PTCT (10,000 shares), Sell PTCT (2,484 shares), Sell PTCT (866 shares), Sell PTCT (642 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-06 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 829 | $56,364 |
| 2026-03-09 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 10,000 | $633,800 |
| 2026-02-20 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 2,484 | $172,290 |
| 2026-01-12 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 866 | $66,206 |
| 2026-01-08 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 642 | $49,742 |
| 2026-01-08 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 1,340 | $103,113 |
| 2026-01-06 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Buy | 18,750 | $0 |
| 2025-04-04 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 897 | $42,114 |
| 2025-02-21 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 795 | $39,830 |
| 2025-02-21 | PTC THERAPEUTICS, INC. (PTCT) | EVP & CHIEF MEDICAL OFFICER | Sell | 962 | $48,215 |
Source: SEC Form 4 filings · as of 2026-04-06